研究者
J-GLOBAL ID:200901087186140750   更新日: 2020年09月17日

三浦 勝浩

ミウラ カツヒロ | Miura Katsuhiro
所属機関・部署:
職名: 准教授
研究分野 (1件): 血液、腫瘍内科学
論文 (52件):
もっと見る
MISC (14件):
  • 前田 嘉信, 近藤 英生, 山本 和彦, 増成 太郎, 三浦 勝浩, 瀧澤 淳, 正木 康史, 村上 純, 富田 直人, 神野 正敏. 再発性/難治性DLBCL患者におけるifosfamide、etoposide、dexamethasone、中程度用量cytarabineを併用したrituximab(R-IDEA)療法に関する第II相研究(A phase II study of rituximab plus ifosfamide, etoposide, dexamethasone and intermediate dose cytarabine(R-IDEA) in patients with relapsed/refractory DL. 日本リンパ網内系学会会誌. 2018. 58. 115-115
  • Hiromichi Takahashi, Sumiko Kobayashi, Katsuhiro Miura, Daisuke Kurita, Yoshihiro Hatta, Masahiko Sugitani, Shimon Otake, Masaru Nakagawa, Masashi Sakagami, Yoshihito Uchino, et al. Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy. BLOOD. 2015. 126. 23
  • Katsuhiro Miura, Jun Konishi, Takaaki Miyake, Makita Masanori, Atsuko Hojo, Yasufumi Masaki, Masatoshi Uno, Jun Ozaki, Chikamasa Yoshida, Daigo Niiya, et al. A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP. BLOOD. 2015. 126. 23
  • Akihiro Uchiike, Tatsuya Hayama, Katsuhiro Miura, Daisuke Tsutsumi, Masatoshi Hayasaka, Yoshihiro Hatta, Masami Takei, Yoshikazu Yoshida. A clinical prediction model for infusion reaction to rituximab. ANNALS OF ONCOLOGY. 2015. 26. 80-80
  • Katsuhiro Miura, Satomi Kiso, Masaru Nakagawa, Hiromichi Takahashi, Yoshito Uchino, Hitomi Kodaira, Noriyoshi Iriyama, Masashi Sakagami, Shimon Ohtake, Sumiko Kobayashi, et al. Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies. BLOOD. 2014. 124. 21
もっと見る
講演・口頭発表等 (8件):
  • Consolidation therapy using 90Y-ibritumomab tiuxetan after bendamustine and rituximab in patients with relapsed follicular lymphoma; a multicenter, phase II study (BRiZ2012)
    (The 24th European Hematology Association congress 2019)
  • Bendamustine and rituximab (BR) followed by 90Y-ibritumomab tiuxetan (90Y-IT) for relapsed follicular lymphoma; a preliminary analysis of a multicenter, prospective phase II study (BRiZ 2012)
    (European Society of Medical Oncology 2018 congress 2018)
  • A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    (57th annual meeting of the American Society of Hematology 2015)
  • Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
    (57th annual meeting of the American Society of Hematology 2015)
  • CLINICAL SIGNIFICANCE OF CO-EXPRESSION OF MYC AND BCL2 PROTEIN IN AGGRESSIVE B-CELL LYMPHOMAS TREATED WITH A SECOND LINE IMMUNOCHEMOTHERAPY
    (20th Congress of European Hematology Association 2015)
もっと見る
学位 (1件):
  • 博士(医学) (日本大学)
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る